ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: David Nathan receives Lifetime Impact Award from Boston Children’s Hospital

November 7, 2014

Six More CCOPS In Funding Range For Recompetition

February 9, 1990

Healy’s “Save Bob” Campaign

January 6, 1995

NCI Told It Needs Overview Of Basic Research For Visibility And To Pursue Breakthroughs

July 14, 1978

Report On Carcinogenesis Testing, Evaluation Submitted to NTP; Calls For Continued Research

September 7, 1984

NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials

March 3, 1989